ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow RMD
ResMed Inc. (RMD) EV/FCF
As of 16 October 2026, ResMed Inc. (RMD) trades at a EV/FCF of 20.7×. Over the past ten years it has ranged from 12.5× (January 2016) to 185× (August 2022); the current reading is higher than 24% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2026 | 16.8× | (25.84%) |
| FY2025 | 22.6× | 4.02% |
| FY2024 | 21.7× | (63.49%) |
| FY2023 | 59.5× | (62.69%) |
| FY2022 | 159× | 173.27% |
| FY2021 | 58.3× | 42.99% |
| FY2020 | 40.8× | (17.25%) |
| FY2019 | 49.3× | 43.52% |
| FY2018 | 34.4× | 4.50% |
| FY2017 | 32.9× | 75.22% |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 16.8× | (7.26%) |
| Mar 2026 | 18.1× | (5.91%) |
| Dec 2025 | 19.2× | (13.60%) |
| Sep 2025 | 22.2× | (1.63%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| SOLV Solventum Corporation compare | −167× |
| MDLN Medline Inc. compare | 17.7× |
| COO The Cooper Companies, Inc. compare | 20.0× |
| BDX Becton, Dickinson and Company compare | 20.4× |
| RMD ResMed Inc. | 20.7× |
| ALC Alcon compare | 22.3× |
| BAX Baxter International Inc. compare | 25.0× |
| WST West Pharmaceutical Services, Inc. compare | 62.1× |
| RGEN Repligen Corporation compare | 159× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement